Published in Prim Care Companion J Clin Psychiatry on December 01, 2002
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ (2000) 6.67
A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med (2002) 5.65
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophr Res (1999) 4.13
Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry (2001) 3.66
Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry (2002) 3.41
Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry (2000) 2.61
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry (2002) 2.59
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry (2000) 2.48
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry (2000) 2.34
A novel augmentation strategy for treating resistant major depression. Am J Psychiatry (2001) 2.05
Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry (2002) 2.02
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry (2000) 1.93
Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry (2002) 1.89
Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry (1999) 1.86
Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry (1989) 1.79
Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry (2002) 1.60
Bodyweight gain with atypical antipsychotics. A comparative review. Drug Saf (2001) 1.53
New atypical antipsychotic medications. J Psychiatr Res (1998) 1.44
Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry (1999) 1.40
A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.30
Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc (1999) 1.25
Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. J Clin Psychiatry (1999) 1.22
Electroencephalographic sleep abnormalities in schizophrenia. Relationship to positive/negative symptoms and prior neuroleptic treatment. Arch Gen Psychiatry (1992) 1.16
Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study. Int Clin Psychopharmacol (2002) 1.11
Olanzapine treatment for post-traumatic stress disorder: an open-label study. Int Clin Psychopharmacol (2001) 1.07
Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry (1998) 1.04
Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. J Clin Psychiatry (2001) 1.00
Expected incidence of tardive dyskinesia associated with atypical antipsychotics. J Clin Psychiatry (2000) 0.96
An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. J Clin Psychiatry (2001) 0.94
Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study. Can J Psychiatry (2001) 0.87
Quetiapine alone and added to a mood stabilizer for serious mood disorders. J Clin Psychiatry (2001) 0.86
Paediatric uses of atypical antipsychotics. Expert Opin Pharmacother (2000) 0.86
Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta Neurol Scand (1981) 0.80
Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation. Biol Psychiatry (1998) 0.79